Peter Leddy, David Harvey, Geoff Alms, Gareth Thomson, Carl Balezentis, Christian Stahlberg, Cellomics and Beckman Coulter, PerkinElmer and Chaim Sheba Medical Center, Invitrogen, Eppendorf, and Clinical Data | GenomeWeb

People

The Biotechnology Institute named Invitrogen's Peter Leddy to its board of directors, the organization said last week.

Leddy is senior vice-president of human resources, a position he's held since July 2005. Prior to Invitrogen, Leddy spent five years with Dell in several management positions, most recently vice-president of human resources for Americas Operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.